

Health Care: Drugs
Impax Laboratories Inc. (IPXL: NASDAQ)
$18.51 0.08 | 0.43%
05/21/13 - 04:00 PM ET
Growth Rates
| GROWTH RATES |
 |
| REVENUE |
 |
| EARNINGS PER SHARE |
 |
| DIVIDENDS |
 |
Portfolios with IPXL
Latest IPXL Headlines from TheStreet
More Financial News for IPXL
Press Releases for IPXL
- UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses On Their Investment In Impax Laboratories Inc. Of Class Action Lawsuit And The Deadline Of May 6, 2013 To Seek A Lead Plaintiff Position - PR Newswire 04.23.13 | 03:04 pm
- Pittsburgh Law Office Of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf Of Shareholders Of Tangoe (TNGO) And Announces Investigations Of Atlantic Power Corp. (AT), Bazaarvoice (BV), Boeing (BA), Caterpillar (CAT), Diodes (DIOD), Harvest Natural Resources (HNR), Hess Corp. (HES), Impax Laboratories ( IPXL), Incyte Corp. (INCY), ITT Educational Services (ESI), - PR Newswire 04.12.13 | 07:04 pm
- Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Impax Laboratories, Inc. To Contact The Firm - PR Newswire 03.29.13 | 09:03 pm
- Impax Pharmaceuticals Announces Presentation Of RYTARYTM (IPX066) (Carbidopa And Levodopa) Extended-Release Capsules Phase III And Open-Label Extension Data At The American Academy Of Neurology 2013 Annual Meeting - Business Wire 03.19.13 | 08:03 am
- Lifshitz Law Firm Announces Class Action Lawsuits Against Affymax, Inc., Impax Laboratories Inc., And Tangoe, Inc. - PR Newswire 03.18.13 | 07:03 pm
- RYTARYTM (IPX066) (Carbidopa And Levodopa) Extended-Release Capsules Phase III And Open-Label Extension Data To Be Presented At The American Academy Of Neurology Conference - Business Wire 03.15.13 | 08:03 am
- Impax Laboratories, Inc. Continues To Ignore FDA Warnings, Causing A Delay In Bringing A New Drug To Market; Robbins Arroyo LLP Investigates On Behalf Of Impax Shareholders - PR Newswire 03.14.13 | 06:03 pm
- Bronstein, Gewirtz & Grossman, LLC Announces That A Class Action Has Been Filed Against Impax Laboratories Inc. - PR Newswire 03.14.13 | 08:03 am
- Impax Laboratories Shareholder Alert: Briscoe Law And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors - Business Wire 03.08.13 | 03:03 pm
- Finkelstein Thompson LLP Announces Investigation Of Impax Laboratories, Inc. - Business Wire 03.07.13 | 04:03 pm
See All Press Releases
Partner Headlines for IPXL